Gene · 5961
PRPH2: peripherin 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PRPH2: peripherin 2. Genes, record 5961. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5961
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P23942 | Peripherin-2 | 346 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents66
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4821560 A2 | 2026-10-14 | 19 | P23942 | Espacenet |
| JP 2026515744 A | 2026-05-19 | 126 | P23942 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 57375 | P23942 | Espacenet |
| EP 4667578 A2 | 2025-12-24 | 147 | P23942 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 541 | P23942 | Espacenet |
| JP 2025131621 A | 2025-09-09 | 147 | P23942 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 541 | P23942 | Espacenet |
| US 12310997 B2 | 2025-05-27 | 13 | P23942 | Espacenet |
| US 12275959 B2 | 2025-04-15 | 19 | P23942 | Espacenet |
| JP 2025039615 A | 2025-03-21 | 19 | P23942 | Espacenet |
1 to 10 of 66
See all 66 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants863
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PRPH2 papers | Newest fiscal year |
|---|---|---|---|
| R01EY010609 | Mechanism of photoreceptor cell degeneration in animal models of retinal diseases | 50 | 2025 |
| R01EY018213 | Defining Barriers to Gene Therapy | 19 | 2025 |
| R01EY018571 | Genetics of early onset retinal diseases | 12 | 2025 |
| R01EY022356 | Molecular Basis of Human Visual System Disorders | 12 | 2025 |
| P30EY000331 | Vision Research Core at UCLA | 11 | 2025 |
| P30CA013696 | Cancer Center Support Grant | 10 | 2025 |
| P30EY001792 | P30 Core Grant for Vision Research | 9 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 9 | 2025 |
| R01EY012910 | Precision Medicine for Inherited Retinal Degenerations | 9 | 2025 |
| R01EY024698 | Gene Editing and Silencing in Phototransduction | 9 | 2025 |
1 to 10 of 863Source NIH's project files
See all 863 nih grantsPapers1,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting Missing Heritability in Rare Inherited Macular Dystrophies. | Genes (Basel) | 2026 | 42650171 | PubTator, text mining | PubMed |
| Homozygous ROM1 frameshift variant associated with late-onset retinal dystrophy. | Ophthalmic Genet | 2026 | 42635054 | PubTator, text mining | PubMed |
| CDHR1-associated retinal degeneration: Clinical phenotypes and therapeutic approaches. | Prog Retin Eye Res | 2026 | 42562233 | PubTator, text mining | PubMed |
| Strategies for Mitigation of Intermediate CO2 Poisoning to Promote Electrocatalytic Efficiency during Urea Oxidation Reaction. | Chem Bio Eng | 2026 | 42376260 | PubTator, text mining | PubMed |
| Clinical manifestations of dual-gene variants in retinitis pigmentosa. | Acta Ophthalmol | 2026 | 42360046 | PubTator, text mining | PubMed |
| Disease and Participant-Related Correlates of Genetic Testing Completion for Hereditary Eye Disorders in a Cohort of over 1400 Patients. | Ophthalmol Sci | 2026 | 42358619 | PubTator, text mining | PubMed |
| Insights into ANKRD11-related epilepsy from 163 people. | Epilepsia | 2026 | 42322264 | PubTator, text mining | PubMed |
| Inherited retinal disease genes with dual inheritance patterns: insights from the IRD-PT registry. | J Med Genet | 2026 | 42321002 | PubTator, text mining | PubMed |
| Investigating PRPH2-associated retinal degeneration patient-reported outcomes in vision-related quality of life. | BMC Ophthalmol | 2026 | 42316356 | PubTator, text mining | PubMed |
| PRPH2-associated retinal disease: dual inheritance and broad phenotypic spectrum in a Portuguese cohort. | Eye (Lond) | 2026 | 42151405 | PubTator, text mining | PubMed |
1 to 10 of 1,698
See all 1,698 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5961
GET https://conductscience.org/api/genes/v1/5961/patents?page=2